Repurposing antimalarial drug lumefantrine for glioblastoma

By Claire Quang | Jun 23, 2020 | 11:40 PM GMT

DISEASE CATEGORY: Cancer

INDICATION: Brain cancer

The antimalarial drug lumefantrine, an FLI1 inhibitor, could treat glioblastoma resistant to radiation and temozolomide. A cell-based screen of

Read the full 236 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE